What’s in a Name? Moving to Neuroscience-Based Nomenclature in Pediatric Psychopharmacology

Author:

Sultan Ryan S.,Correll Christoph U.,Zohar Joseph,Zalsman Gil,Veenstra-VanderWeele Jeremy

Funder

National Institute of Mental Health

Patient-Centered Outcomes Research Institute

Bendheim Foundation, Janssen, and Takeda

Lundbeck

Servier

Brainsway

Pfizer

National Institutes of Health

Health Resources and Services Administration

Roche Pharmaceuticals

Novartis

SynapDx

Seaside Therapeutics

Forest

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Developmental and Educational Psychology

Reference7 articles.

1. A review of the current nomenclature for psychotropic agents and an introduction to the neuroscience-based nomenclature;Zohar;Euro Neuropsychopharmacol,2015

2. Efficacy and safety of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and placebo for common psychiatric disorders among children and adolescents: a systematic review and meta-analysis;Locher;JAMA Psychiatry,2017

3. Update on the use of SSRIs and SNRIs with children and adolescents in clinical practice;Jane Garland;J Can Acad Child Adolesc Psychiatry,2016

4. First- and second-generation antipsychotics in children and young adults: systematic review update;Pillay,2017

5. Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics;Correll;J Clin Psychiatry,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3